Efficacy and safety of LY01005 versus goserelin implant in Chinese patients with prostate cancer: A multicenter, randomized, open-label, phase III, non-inferiority trial

BACKGROUND: LY01005 (Goserelin acetate sustained-release microsphere injection) is a modified gonadotropin-releasing hormone (GnRH) agonist injected monthly. This phase III trial study aimed to evaluated the efficacy and safety of LY01005 in Chinese patients with prostate cancer. METHODS: We conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Chengyuan, Wang, Zengjun, Lin, Tianxin, Liu, Zhiyu, Han, Weiqing, Zhang, Xuhui, Liang, Chao, Liu, Hao, Yu, Yang, Xu, Zhenzhou, Liu, Shuang, Wang, Jingen, Jia, Linghua, Yao, Xin, Liao, Wenfeng, Fu, Cheng, Tan, Zhaohui, He, Guohua, Zhu, Guoxi, Fan, Rui, Yang, Wenzeng, Chen, Xin, Liu, Zhizhong, Zhong, Liqiang, Shi, Benkang, Ding, Degang, Chen, Shubo, Wei, Junli, Yao, Xudong, Chen, Ming, Lu, Zhanpeng, Xie, Qun, Hu, Zhiquan, Wang, Yinhuai, Guo, Hongqian, Fan, Tiwu, Liang, Zhaozhao, Chen, Peng, Wang, Wei, Xu, Tao, Li, Chunsheng, Xing, Jinchun, Liao, Hong, He, Dalin, Wu, Zhibin, Yu, Jiandi, Feng, Zhongwen, Yang, Mengxiang, Dou, Qifeng, Zeng, Quan, Li, Yuanwei, Gou, Xin, Zhou, Guangchen, Wang, Xiaofeng, Zhu, Rujian, Zhang, Zhonghua, Zhang, Bo, Tan, Wanlong, Qu, Xueling, Sun, Hongliang, Gan, Tianyi, Ye, Dingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278759/
https://www.ncbi.nlm.nih.gov/pubmed/37010251
http://dx.doi.org/10.1097/CM9.0000000000002638

Ejemplares similares

Ejemplares similares